Tekla Healthcare Investors Stock Performance
| HQH Stock | USD 17.40 0.10 0.58% |
The entity has a beta of 0.63, which indicates possible diversification benefits within a given portfolio. As returns on the market increase, Tekla Healthcare's returns are expected to increase less than the market. However, during the bear market, the loss of holding Tekla Healthcare is expected to be smaller as well. At this point, Tekla Healthcare Inv has a negative expected return of -0.13%. Please make sure to validate Tekla Healthcare's kurtosis, and the relationship between the maximum drawdown and day median price , to decide if Tekla Healthcare Inv performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Tekla Healthcare Investors has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Stock's basic indicators remain strong and the recent confusion on Wall Street may also be a sign of long-lasting gains for the firm traders. ...more
Actual Historical Performance (%)
One Day Return 0.58 | Five Day Return 1.16 | Year To Date Return 3.14 | Ten Year Return (46.66) | All Time Return 78.46 |
Forward Dividend Yield 0.1434 | Payout Ratio 1.2672 | Forward Dividend Rate 2.48 | Dividend Date 2018-12-31 | Ex Dividend Date 2024-11-21 |
1 | Acquisition by William Reardon of 646 shares of Tekla Healthcare at 15.8551 subject to Rule 16b-3 | 09/06/2024 |
2 | Disposition of 1606 shares by Bonney Michael W of Tekla Healthcare at 25.037 subject to Rule 16b-3 | 09/20/2024 |
| Tekla Healthcare dividend paid on 30th of September 2024 | 09/30/2024 |
3 | Saba Capital Management Reduces Stake in abrdn Healthcare Invest - GuruFocus.com | 10/23/2024 |
4 | Acquisition by Dimartino Rose of 1000 shares of Tekla Healthcare at 18.88 subject to Rule 16b-3 | 11/22/2024 |
| Begin Period Cash Flow | 792.00 |
Tekla |
Tekla Healthcare Relative Risk vs. Return Landscape
If you would invest 1,895 in Tekla Healthcare Investors on August 30, 2024 and sell it today you would lose (155.00) from holding Tekla Healthcare Investors or give up 8.18% of portfolio value over 90 days. Tekla Healthcare Investors is generating negative expected returns assuming volatility of 0.9652% on return distribution over 90 days investment horizon. In other words, 8% of stocks are less volatile than Tekla, and above 99% of all equities are expected to generate higher returns over the next 90 days. Expected Return |
| Risk |
Tekla Healthcare Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Tekla Healthcare's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Tekla Healthcare Investors, and traders can use it to determine the average amount a Tekla Healthcare's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.1332
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | HQH |
Estimated Market Risk
| 0.97 actual daily | 8 92% of assets are more volatile |
Expected Return
| -0.13 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.13 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Tekla Healthcare is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Tekla Healthcare by adding Tekla Healthcare to a well-diversified portfolio.
Tekla Healthcare Fundamentals Growth
Tekla Stock prices reflect investors' perceptions of the future prospects and financial health of Tekla Healthcare, and Tekla Healthcare fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Tekla Stock performance.
| Return On Equity | 0.0734 | ||||
| Return On Asset | -7.0E-4 | ||||
| Profit Margin | 7.31 % | ||||
| Operating Margin | (0.01) % | ||||
| Current Valuation | 880.86 M | ||||
| Shares Outstanding | 50.62 M | ||||
| Price To Earning | 3.38 X | ||||
| Price To Book | 0.87 X | ||||
| Price To Sales | 88.36 X | ||||
| Revenue | 58.12 M | ||||
| Gross Profit | 8.27 M | ||||
| EBITDA | 56.33 M | ||||
| Net Income | 56.33 M | ||||
| Cash And Equivalents | 62 | ||||
| Total Debt | 1.15 M | ||||
| Debt To Equity | 0.01 % | ||||
| Current Ratio | 3.21 X | ||||
| Book Value Per Share | 19.91 X | ||||
| Cash Flow From Operations | (65.41 M) | ||||
| Earnings Per Share | 1.31 X | ||||
| Market Capitalization | 880.87 M | ||||
| Total Asset | 932.49 M | ||||
| Retained Earnings | 5.97 M | ||||
About Tekla Healthcare Performance
By evaluating Tekla Healthcare's fundamental ratios, stakeholders can gain valuable insights into Tekla Healthcare's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Tekla Healthcare has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Tekla Healthcare has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | 0.07 | 0.08 | |
| Return On Assets | 0.07 | 0.08 | |
| Return On Equity | 0.07 | 0.08 |
Things to note about Tekla Healthcare Inv performance evaluation
Checking the ongoing alerts about Tekla Healthcare for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Tekla Healthcare Inv help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Tekla Healthcare Inv generated a negative expected return over the last 90 days | |
| Tekla Healthcare Inv has high likelihood to experience some financial distress in the next 2 years | |
| Tekla Healthcare Investors has about 62 in cash with (65.41 M) of positive cash flow from operations. | |
| Latest headline from MacroaxisInsider: Acquisition by Dimartino Rose of 1000 shares of Tekla Healthcare at 18.88 subject to Rule 16b-3 |
- Analyzing Tekla Healthcare's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Tekla Healthcare's stock is overvalued or undervalued compared to its peers.
- Examining Tekla Healthcare's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Tekla Healthcare's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Tekla Healthcare's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Tekla Healthcare's stock. These opinions can provide insight into Tekla Healthcare's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Tekla Stock analysis
When running Tekla Healthcare's price analysis, check to measure Tekla Healthcare's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tekla Healthcare is operating at the current time. Most of Tekla Healthcare's value examination focuses on studying past and present price action to predict the probability of Tekla Healthcare's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tekla Healthcare's price. Additionally, you may evaluate how the addition of Tekla Healthcare to your portfolios can decrease your overall portfolio volatility.
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments |